Результати пошуку - Cesare Gridelli

Уточнити результати
  1. 1
    The ELVIS Trial: A Phase III Study of Single-Agent Vinorelbine as First-Line Treatment in Elderly Patients with Advanced Non-Small Cell Lung Cancer

    The ELVIS Trial: A Phase III Study of Single-Agent Vinorelbine as First-Line Treatment in Elderly Patients with Advanced Non-Small Cell Lung Cancer за авторством Cesare Gridelli

    Опубліковано 2001
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  2. 2
    Targeting Immunometabolism Mediated by CD73 Pathway in EGFR-Mutated Non-small Cell Lung Cancer: A New Hope for Overcoming Immune Resistance

    Targeting Immunometabolism Mediated by CD73 Pathway in EGFR-Mutated Non-small Cell Lung Cancer: A New Hope for Overcoming Immune Resistance за авторством Anna Passarelli, Michele Aieta, Alessandro Sgambato, Cesare Gridelli

    Опубліковано 2020
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  3. 3
    Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy

    Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy за авторством Enriqueta Felip, Cesare Gridelli, Paul Baas, Rafael Rosell, Rolf A. Stahel

    Опубліковано 2011
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  4. 4
    Immunotherapy in the first-line treatment of elderly patients with advanced non-small-cell lung cancer: results of an International Experts Panel Meeting by the Italian Association of Thoracic Oncology (AIOT)

    Immunotherapy in the first-line treatment of elderly patients with advanced non-small-cell lung cancer: results of an International Experts Panel Meeting by the Italian Association... за авторством Cesare Gridelli, Solange Peters, Vamsidhar Velcheti, Ilaria Attili, Filippo de Marinis

    Опубліковано 2023
    Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  5. 5
    Overcoming resistance to targeted therapies in NSCLC: current approaches and clinical application

    Overcoming resistance to targeted therapies in NSCLC: current approaches and clinical application за авторством Paolo Maione, Paola Claudia Sacco, Assunta Sgambato, Francesca Casaluce, Antônio Rossi, Cesare Gridelli

    Опубліковано 2015
    Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  6. 6
    Erlotinib in Non-Small Cell Lung Cancer Treatment: Current Status and Future Development

    Erlotinib in Non-Small Cell Lung Cancer Treatment: Current Status and Future Development за авторством Cesare Gridelli, Maria Anna Bareschino, Clorinda Schettino, Antônio Rossi, Paolo Maione, Fortunato Ciardiello

    Опубліковано 2007
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  7. 7
    Potential role of molecularly targeted therapy in the management of advanced nonsmall cell lung carcinoma in the elderly

    Potential role of molecularly targeted therapy in the management of advanced nonsmall cell lung carcinoma in the elderly за авторством Cesare Gridelli, Erminia Massarelli, Paolo Maione, Antônio Rossi, Roy S. Herbst, Amir Onn, Fortunato Ciardiello

    Опубліковано 2004
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  8. 8
    Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up за авторством Solange Peters, Alex A. Adjei, Cesare Gridelli, Martin Reck, K.M. Kerr, Enriqueta Felip

    Опубліковано 2012
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  9. 9
    Vascular Disrupting Agents: A Novel Mechanism of Action in the Battle Against Non-Small Cell Lung Cancer

    Vascular Disrupting Agents: A Novel Mechanism of Action in the Battle Against Non-Small Cell Lung Cancer за авторством Cesare Gridelli, Antônio Rossi, Paolo Maione, Emanuela Rossi, Vincenzo Castaldo, Paola Claudia Sacco, Giuseppe Colantuoni

    Опубліковано 2009
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  10. 10
    Real-world treatment patterns for patients receiving second-line and third-line treatment for advanced non-small cell lung cancer: A systematic review of recently published studies

    Real-world treatment patterns for patients receiving second-line and third-line treatment for advanced non-small cell lung cancer: A systematic review of recently published studies за авторством Jessica Davies, Manali I. Patel, Cesare Gridelli, Filippo de Marinis, Daniel Waterkamp, Margaret McCusker

    Опубліковано 2017
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  11. 11
    Future Scenarios for the Treatment of Advanced Non-Small Cell Lung Cancer: Focus on Taxane-Containing Regimens

    Future Scenarios for the Treatment of Advanced Non-Small Cell Lung Cancer: Focus on Taxane-Containing Regimens за авторством Francesco Grossi, Kaoru Kubota, Federico Cappuzzo, Filippo de Marinis, Cesare Gridelli, Marianna Aita, Jean‐Yves Douillard

    Опубліковано 2010
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  12. 12
    First-line immunotherapy in advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an International Expert Panel Meeting by the Italian Association of Thoracic Oncology

    First-line immunotherapy in advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an International Expert Panel Meeting by the Italian Association... за авторством Cesare Gridelli, Solange Peters, Tony Mok, Patrick M. Forde, Martin Reck, Ilaria Attili, Filippo de Marinis

    Опубліковано 2021
    Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  13. 13
    Predictive biomarkers of immunotherapy for non-small cell lung cancer: results from an Experts Panel Meeting of the Italian Association of Thoracic Oncology

    Predictive biomarkers of immunotherapy for non-small cell lung cancer: results from an Experts Panel Meeting of the Italian Association of Thoracic Oncology за авторством Cesare Gridelli, Andrea Ardizzoni, Massimo Barberis, Federico Cappuzzo, Francesca Casaluce, Romano Danesi, Giancarlo Troncone, Filippo de Marinis

    Опубліковано 2017
    Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  14. 14
    Erlotinib in Advanced Non-small Cell Lung Cancer: Efficacy and Safety Findings of the Global Phase IV Tarceva Lung Cancer Survival Treatment Study

    Erlotinib in Advanced Non-small Cell Lung Cancer: Efficacy and Safety Findings of the Global Phase IV Tarceva Lung Cancer Survival Treatment Study за авторством Martin Reck, Nico van Zandwijk, Cesare Gridelli, Zoltán Balikó, Danny Rischin, Simon Allan, Maciej Krzakowski, David F. Heigener

    Опубліковано 2010
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  15. 15
    Management of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology

    Management of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology за авторством Athanasios Pallis, Cesare Gridelli, Ulrich Wedding, Corinne Faivre‐Finn, Paolo Veronesi, Michael T. Jaklitsch, Andrea Luciani, Mary O’Brien

    Опубліковано 2014
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  16. 16
    Individual Patient Data Meta-Analysis of Docetaxel Administered Once Every 3 Weeks Compared With Once Every Week Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer

    Individual Patient Data Meta-Analysis of Docetaxel Administered Once Every 3 Weeks Compared With Once Every Week Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer за авторством Massimo Di Maïo, Francesco Perrone, Paolo Chiodini, Ciro Gallo, Carlos Camps, Wolfgang Schuette, Élisabeth Quoix, Chun-Ming Tsai, Cesare Gridelli

    Опубліковано 2007
    Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  17. 17
    EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts’ opinion for the treatment of non-small-cell lung cancer in an elderly population

    EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts’ opinion for the treatment of non-small-cell lung cancer in an elderl... за авторством Athanasios Pallis, Cesare Gridelli, Jan P. van Meerbeeck, Laurent Greillier, Ulrich Wedding, Didier Lacombe, John J. Welch, Chandra P. Belani, Matti Aapro

    Опубліковано 2009
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  18. 18
    Treatment of Elderly Patients With Non–Small-Cell Lung Cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology

    Treatment of Elderly Patients With Non–Small-Cell Lung Cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology за авторством Cesare Gridelli, Lodovico Balducci, Fortunato Ciardiello, Massimo Di Maïo, Enriqueta Felip, Corey J. Langer, Rogério Lilenbaum, Federica Perrone, Suresh Senan, Filippo de Marinis

    Опубліковано 2015
    Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  19. 19
    Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel

    Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel за авторством Cesare Gridelli, Andrea Ardizzoni, Thierry Le Chevalier, C. Manegold, Federica Perrone, N. Thatcher, Nico van Zandwijk, Massimo Di Maïo, Olga Martelli, Filippo de Marinis

    Опубліковано 2004
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  20. 20
    Meta-Analysis of Single-Agent Chemotherapy Compared With Combination Chemotherapy As Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer

    Meta-Analysis of Single-Agent Chemotherapy Compared With Combination Chemotherapy As Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer за авторством Massimo Di Maïo, Paolo Chiodini, Vassilis Georgoulias, Dora Hatzidaki, Koji Takeda, Floris M Wachters, Vittorio Gebbia, Egbert F. Smit, Alessandro Morabito, Ciro Gallo, Francesco Perrone, Cesare Gridelli

    Опубліковано 2009
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:

Інструменти для пошуку: